A Pilot Study of Tobacco Screening and Referral for Smoking Cessation Program among HIV-Infected Patients in France

Archive ouverte

Parienti, Jean-Jacques | Merzougui, Zine | de La Blanchardière, Arnaud | Dargère, Sylvie | Feret, Philippe | Le Maitre, Béatrice | Verdon, Renaud

Edité par CCSD ; Sage Publications -

International audience. Background: The prevalence of tobacco smoking is high among patients living with HIV, supporting the need for effectivetargeted interventions. Materials and Methods: All current smokers at our outpatient HIV clinic were invited to participate in asmoking cessation program. Results: Of the 716 patients living with HIV, 280 (39%) reported active smoking and were younger,more recently HIV infected and more frequently infected due to intravenous drug use (IDU). One hundred forty-seven (53%)smokers agreed to participate in the smoking cessation program and had a higher Fagerstro¨m score and were less likely IDU.During follow-up, 41 (28%) smokers withdrew from the program. After 6 months, 60 (57%) of the 106 smokers who completedthe intervention had stopped tobacco smoking and were more likely to use varenicline, adjusting for a history of depression.Conclusion: Our smoking cessation program was feasible. However, strategies to reach and retain in smoking cessationprogram specific groups such as IDU are needed to improve the smoking cessation cascade.

Consulter en ligne

Suggestions

Du même auteur

Long term complications of antiretroviral therapy : adherence, resistance and metabolic abnormalities. Complications à long terme des traitements antirétroviraux : observance, résistances et troubles métaboliques

Archive ouverte | Parienti, Jean-Jacques | CCSD

The therapeutic advance in the field of the Virus of the Human Immunodeficiency (HIV) infection transformed the prognostic of this pathology. The HIV-positive persons experience the same difficulties met in the other chronic disea...

Methodological standards in non-inferiority AIDS trials: moving from adherence to compliance.

Archive ouverte | Parienti, Jean-Jacques | CCSD

BACKGROUND: The interpretation of the results of active-control trials regarding the efficacy and safety of a new drug is important for drug registration and following clinical use. It has been suggested that non-inferiority and e...

Forgiveness of an intermittent HIV treatment strategy

Archive ouverte | Parienti, Jean-Jacques | CCSD

International audience

Chargement des enrichissements...